Kodiak Sciences, Inc. (KOD)
99.18
+4.92
(+5.22%)
USD |
NASDAQ |
Oct 09, 13:59
Kodiak Sciences Price : 99.18 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 90.01 | 94.95 | 89.54 | 94.26 | 1.529M |
| Oct 07, 2026 | 91.74 | 94.25 | 89.91 | 91.08 | 1.307M |
| Oct 06, 2026 | 92.86 | 95.54 | 89.70 | 92.34 | 1.483M |
| Oct 05, 2026 | 92.86 | 96.64 | 87.58 | 93.81 | 3.236M |
| Oct 02, 2026 | 98.95 | 98.95 | 88.63 | 94.45 | 2.677M |
| Oct 01, 2026 | 95.41 | 104.00 | 93.95 | 98.46 | 3.795M |
| Sep 30, 2026 | 93.83 | 98.80 | 88.48 | 94.80 | 4.920M |
| Sep 29, 2026 | 87.20 | 93.14 | 83.64 | 91.12 | 6.047M |
| Sep 28, 2026 | 61.70 | 95.77 | 60.49 | 89.92 | 38.55M |
| Sep 25, 2026 | 33.03 | 33.70 | 31.00 | 32.35 | 2.277M |
| Sep 24, 2026 | 30.90 | 33.78 | 29.81 | 33.22 | 1.291M |
| Sep 23, 2026 | 34.10 | 34.48 | 30.80 | 31.52 | 1.053M |
| Sep 22, 2026 | 32.71 | 34.45 | 32.46 | 33.80 | 1.038M |
| Sep 21, 2026 | 33.04 | 33.34 | 32.00 | 32.42 | 666415.0 |
| Sep 18, 2026 | 32.78 | 32.82 | 31.54 | 32.71 | 1.609M |
| Sep 17, 2026 | 33.32 | 33.69 | 32.72 | 32.85 | 826147.0 |
| Sep 16, 2026 | 33.12 | 33.49 | 31.62 | 32.77 | 707944.0 |
| Sep 15, 2026 | 32.71 | 33.29 | 32.38 | 32.99 | 819594.0 |
| Sep 14, 2026 | 33.21 | 33.89 | 32.96 | 33.14 | 547794.0 |
| Sep 11, 2026 | 33.10 | 34.07 | 32.31 | 32.89 | 682568.0 |
| Sep 10, 2026 | 33.29 | 33.41 | 32.61 | 32.87 | 668385.0 |
| Sep 09, 2026 | 35.00 | 35.92 | 33.73 | 33.78 | 643554.0 |
| Sep 08, 2026 | 34.71 | 35.27 | 33.92 | 35.07 | 673163.0 |
| Sep 04, 2026 | 35.98 | 36.62 | 35.18 | 35.36 | 675921.0 |
| Sep 03, 2026 | 37.60 | 37.82 | 36.20 | 36.36 | 460191.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 748.20 |
| AbbVie, Inc. | 277.06 |
| Mirum Pharmaceuticals, Inc. | 87.14 |
| ACADIA Pharmaceuticals, Inc. | 19.82 |
| Alnylam Pharmaceuticals, Inc. | 232.24 |
Price Related Metrics
| PEG Ratio | -2.232 |
| Price to Book Value | 102.00 |
| Earnings Yield | -4.23% |
| Market Cap | 6.232B |
| PEGY Ratio | -2.232 |